Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control Study. [electronic resource]
Producer: 20190318Description: e667-e673 p. digitalISSN:- 1938-0690
- Adenocarcinoma -- drug therapy
- Aged
- Antineoplastic Agents, Immunological -- therapeutic use
- B7-H1 Antigen -- antagonists & inhibitors
- Biomarkers, Tumor -- metabolism
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Case-Control Studies
- Female
- Follow-Up Studies
- Humans
- Lung Diseases, Interstitial -- drug therapy
- Lung Neoplasms -- drug therapy
- Male
- Prognosis
- Stromal Cells -- metabolism
- Survival Rate
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.